COMMUNIQUÉS West-GlobeNewswire

Transactions under Novozymes’ stock buyback program

30/09/2019 - 14:50

Please read the full announcement in the attached PDF Attachment 2019_38_Stock_Buybackprogram_EN

Homology Medicines to Participate in Conferences in October

30/09/2019 - 14:49

BEDFORD, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today presentations at the following industry, investor and scientific conferences: 2019 [...]

Clear Benefit for Patients with Synovial Sarcoma Demonstrated in Updated Data from Ongoing Phase 1 Trial with ADP-A2M4 Presented at ESMO

30/09/2019 - 14:45

- Clinical responses in 7 out of 12 patients with synovial sarcoma, and clinical benefit in 11 out 12 patients - PHILADELPHIA and OXFORDSHIRE, United Kingdom, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics [...]

Golden Leaf Holdings Announces California Expansion

30/09/2019 - 14:45

Popular Cannabis-Infused Chalice Farms Chews Product Line Launched into Largest Cannabis Market in the United States Company Partners with Leading California Co-packer and Distributor TORONTO, Sept. 30, 2019 (GLOBE [...]

Acasti Pharma Announces Additional Phase 3 Milestones Reached, and Remains on Track to Report Topline Results for TRILOGY 1 in December 2019 and TRILOGY 2 in January 2020

30/09/2019 - 14:35

Nearly 80% of randomized patients have completed the studies Data clean-up for TRILOGY 1 is 90% completed Plan to present full data set including results for key secondary and exploratory endpoints of interest such as [...]

Sharps Compliance Adds Susan Vogt to Board of Directors

30/09/2019 - 14:30

HOUSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (NASDAQ: SMED) (“Sharps” or the “Company”), a leading full-service national provider of comprehensive waste management solutions including medical, [...]

Turning Point Therapeutics Announces FDA Clearance of Investigational New Drug Application for TPX-0046, a Novel RET/SRC Inhibitor

30/09/2019 - 14:30

SAN DIEGO, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced clearance by the U.S. [...]

Ultragenyx and Kyowa Kirin Announce U.S. FDA Approves Label Update for Crysvita® (burosumab) for the Treatment of X-Linked Hypophosphatemia (XLH)

30/09/2019 - 14:30

Expanded Label Includes Additional Clinical Data Highlighting Superiority Over Conventional Therapy for Pediatric Patients and Extends Current U.S. Indication to Patients Aged Six Months and Older Expanded Label [...]

Immunoscore to support Immuno-oncology and microbiome research within the ONCOBIOME consortium

30/09/2019 - 14:00

Immunoscore® to support Immuno-oncology and microbiome research within the ONCOBIOME consortium A 15M€ European granted consortium led by Laurence Zitvogel from Gustave Roussy in Villejuif. HalioDx task is to link [...]

Teneobio Licenses Oncology Multispecific Product to Janssen

30/09/2019 - 14:00

NEWARK, Calif., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Teneobio, Inc., a clinical-stage biotechnology company developing engineered bispecific antibodies for the treatment of cancer announced today that as a result of its [...]

Intellia Therapeutics to Present at October Healthcare Investor Conferences

30/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and [...]

HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference

30/09/2019 - 14:00

TUCSON, Ariz., Sept. 30, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski, [...]

electroCore Appoints Medical Technology Veteran Daniel S. Goldberger as Chief Executive Officer

30/09/2019 - 14:00

BASKING RIDGE, N.J., Sept. 30, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the appointment of Daniel S. Goldberger as Chief Executive [...]

Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 for HPV16-driven Head and Neck Squamous Cell Carcinoma

30/09/2019 - 14:00

CAMBRIDGE, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate [...]

TYME Presents Supporting Data at ESMO 2019 from TYME-88-Panc Phase II Study Demonstrating Overall Survival Trends, Well Tolerated Safety, and Quality of Life Data in Patients with Advanced Pancreatic Cancer

30/09/2019 - 14:00

TYME launched its multicenter randomized controlled pivotal stage of TYME-88-Panc trial for use of SM-88 in patients with third-line pancreatic cancer based on these clinical outcomes SM-88 is an oral, investigational [...]

ORYZON Presents Positive Efficacy Results on Iadademstat in ED-SCLC Patients at ESMO-2019

30/09/2019 - 14:00

75% of responses in the first 8 evaluable patients treated with the triple combination of iadademstat plus carboplatin-etoposide Main toxicity of the combination is hematological Iadademstat alone is safe, does not [...]

Further Data Review Shows Major Clinical Benefits From Veyonda®

30/09/2019 - 14:00

Comparative data shows Veyonda® significantly boosts the effectiveness of a promising new form of radiation therapy ( 177 LuPSMA) in advanced prostate cancer 177 LuPSMA therapy is the subject of a recent US$6 billion [...]

Kaleido Biosciences Announces Appointment of Jean Mixer to its Board of Directors

30/09/2019 - 14:00

LEXINGTON, Mass., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a chemistry-driven approach to leveraging the microbiome organ to treat disease and [...]

Intra-Cellular Therapies to Present at the 2019 Cantor Global Healthcare Conference

30/09/2019 - 14:00

NEW YORK, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]